American Century Companies Inc. reduced its position in shares of Verona Pharma plc (NASDAQ:VRNA – Free Report) by 29.3% in ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Verona Pharma (VRNA) has amended its existing strategic financing agreements by repaying the revenue interest purchase and sale agreement and ...

Verona Pharma plc's Ohtuvayre, approved for COPD, has driven the Pharma's stock up >350%, but intense competition and high valuation prompted a downgrade to “Hold”. Despite early success ...

Atria Investments Inc trimmed its holdings in shares of Verona Pharma plc (NASDAQ:VRNA – Free Report) by 27.4% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned ...

In this article, we are going to take a look at where Verona Pharma plc (NASDAQ:VRNA) stands against other stocks that Jim Cramer discussed recently. Jim Cramer, host of Mad Money, expressed his ...

Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...

(RTTNews) - Verona Pharma plc (VRNA), Friday announced some strategic changes in its capital structure, increasing the company's financial flexibility and simplifying its balance sheet. The ...

Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance ...

Drug approvals by the US Food and Drug Administration fell more than 15% in 2024, but smaller pharmaceutical companies are ...

RIPSA interests repurchasedTerm loan facility increased to $450 million with more favorable termsAccess to up to an additional $200 millionLONDON ...

Investors with a lot of money to spend have taken a bearish stance on Verona Pharma (NASDAQ:VRNA). And retail traders should know. We noticed this today when the trades showed up on publicly ...